Advertisement

Topics

Companies Related to "Concurrent Chemoradiation With Cisplatin Every 3 Week in Advanced Cervical Cancer" [Most Relevant Company Matches] RSS

07:14 EST 21st November 2017 | BioPortfolio

Here are the most relevant search results for "Concurrent Chemoradiation With Cisplatin Every 3 Week in Advanced Cervical Cancer" found in our extensive corporate database of over 50,000 company records.

Showing "Concurrent Chemoradiation With Cisplatin Every Week Advanced Cervical" Companies 1–25 of 2,200+

Tuesday 21st November 2017

Step Pharma

Step Pharma is focused on the development of a novel class of oral nucleotide synthesis inhibitors targeting CTPS1 for the improved treatment of a range of autoimmune diseases. The company has identified several series of CTPS1 inhibitors, with the most advanced series currently undergoing lead optimization.


Monday 20th November 2017

Cigna Corporation and Good Samaritan Health System

The Good Samaritan Health System, which includes Regional Medical Center of San Jose and Good Samaritan Hospital-as well as three surgical centers and three Care Now Urgent Care centers, is committed to providing quality healthcare to residents throughout the greater Silicon Valley community. Good Samaritan Health provides a host of technologically-advance...

Universal Diagnostics

Universal Diagnostics (UDX) is an innovative biomedicine company focused on early detection of cancer. By combining world-leading expertise in metabolomics with advanced bioinformatics, UDX is developing simple to use, non-invasive tests to detect cancers early. The first test in development is for the detection of colorectal cancer and precancerous adenom...


Wednesday 8th November 2017

PinnacleCare

PinnacleCare is the premier private health advisory company, helping members make better healthcare decisions through advanced research and access to specialists, coordinated by advisors and physicians who manage all aspects of members’ healthcare. PinnacleCare facilitates appointments, collects and maintain medical records online, and helps members d...

Western Digital Corp.

Western Digital creates environments for data to thrive. The company is driving the innovation needed to help customers capture, preserve, access and transform an ever-increasing diversity of data. Everywhere data lives, from advanced data centers to mobile sensors to personal devices, our industry-leading solutions deliver the possibilities of data.

Tuesday 7th November 2017

OncoResponse

OncoResponse discovers and develops highly targeted and immuno-oncology therapeutic antibodies against novel cancer targets. Our most advanced program, ONCR-201 is an anti-EMP2 fully-human monoclonal antibody being developed for female malignancies. The OncoResponse discovery engine is working to increase the success rate of cancer immunotherapies by ident...

Cloudticity

Cloudticity helps healthcare customers design, build, migrate, and manage HIPAA-compliant applications on Amazon Web Services. Based in Seattle with an international footprint, Cloudticity customers include healthcare providers, payers, and companies that provide software and services to the healthcare industry. Cloudticity is an AWS Advanced Partner, Audi...

Wednesday 1st November 2017

Kaleido Biosciences

Kaleido Biosciences is a clinical-stage biotechnology company engaged in the development of novel chemistries that unlock the power of the microbiome to revolutionize health. The Company has built the first R&D engine to systematically create, discover, and develop interventions that activate metabolic processes in the microbiome to treat disease and maint...

Syros Pharmaceuticals, Inc.

Syros Pharmaceuticals is pioneering the understanding of the non-coding region of the genome to advance a new wave of medicines that control expression of disease-driving genes. Syros has built a proprietary platform that is designed to systematically and efficiently analyze this unexploited region of DNA in human disease tissue to identify and drug novel ...

Symbiotix Biotherapies, Inc.

Symbiotix Biotherapies, Inc. is a pioneering microbiome company founded on the basis of over two decades of research at Brigham & Women’s Hospital/Harvard Medical School, California Institute of Technology and Dartmouth College. Symbiotix is developing a novel class of Treg-modulating therapeutics based on molecules derived from the human microbiome. ...

Thursday 26th October 2017

Shaun T

Shaun T is a world-renowned health and fitness expert, TV host, motivator and creator of the best-selling fitness programs including INSANITY, HIP HOP ABS, FOCUS T25, INSANITY MAX:30 and CIZE. In June 2017, Shaun T released his new program, SHAUN WEEK, which was another mega-hit, reaching 1 million downloads in 6 days. He has hosted several primetime TV se...

Maryland Tech Council (MTC) and FounderTrac

The Maryland Tech Council (MTC) is the largest technology trade group serving the advanced technology and biotechnology communities of Maryland. MTC’s mission is to advocate for the interests of the technology community, further the role of technology in the Maryland economy, and nurture an environment where technology companies can collaborate, grow ...

Sancilio Pharmaceuticals Company, Inc.

Sancilio Pharmaceuticals Company, Inc. (SPCI) is a fully integrated, specialty pharmaceutical company focused on developing, manufacturing and commercializing pharmaceutical products, including those based on our proprietary Advanced Lipid Technologies™ (ALT™) platform. SPCI is pursuing treatments for sickle cell disease, short bowel syndrome and ...

Monday 23rd October 2017

E Ink Holdings

E Ink Holdings Inc. (8069.TWO), based on technology from MIT’s Media Lab, has transformed and defined the eReader market and is redefining the signage, architecture and design, mobile, wearable and retail markets with its ePaper technology, enabling a new multi-billion dollar market in less than 10 years. Its corporate philosophy aims to deliver revol...

Wednesday 18th October 2017

Dune Medical Devices Ltd

Dune Medical Devices is engaged in the development and commercialization of highly advanced, real-time, tissue characterization devices. Dune's devices enable complete, residual-free, therapeutic excisions.Led by a team of medical device veterans Dune Medical has developed a powerful platform technology for real-time identification and localization of sub-millimeter cancer cell clusters. Embedded ...

Tuesday 17th October 2017

M3 Biotechnology, Inc.

M3 Biotechnology is a clinical stage company with a novel platform of disease-modifying regenerative therapies particularly relevant to neurodegenerative diseases, with a focus on Alzheimer’s. M3’s lead asset, NDX-1017, modifies growth factor systems and is advanced as a first-in-class, disease-modifying treatment with the potential to restore lo...

Thursday 12th October 2017

Vennli

Vennli is a voice of the marketplace solution, delivering customer insights through the company’s cloud-based platform. Vennli’s approach to business intelligence uses a proprietary, proven competitive differentiation model within an advanced analytics and data visualization application. The two-pronged approach of delivering an easy-to-use platf...

Detox Day Spa

Our mission at Detox Spa Services is to help metro Detroit residents get to a healthier state of mind, body and soul. The concept centers on providing 2-3 detox services to clients, once a week in an hour. Services include: Alkaline water therapy, bioflavonoid therapy, detox foot baths, detoxifying facials, HydroMassage, infrared sauna detox and reflexolog...

Monday 9th October 2017

GNI Group Ltd.

GNI Group Ltd. is listed on the Tokyo Stock Exchange Mothers Market, Code 2160, with headquarters in Tokyo and subsidiaries in Hong Kong, Shanghai, Beijing and the United States. In the United States, GNI Group has, through its wholly-owned subsidiary GNI USA, Inc., a consolidated subsidiary, Berkeley Advanced Biomaterials LLC. which is a developer and man...

Express Logic, Inc.

Headquartered in San Diego, CA, with field offices in Redditch, UK, and Hanover and Munich, Germany, Express Logic offers the most advanced run-time solutions and development tools for deeply embedded applications, including its popular ThreadX® RTOS, the high-performance NetX™ TCP/IP stack, the FileX® embedded FAT-compatible file system, the US...

Monday 2nd October 2017

National Breast Center

National Breast Center located in Alexandria, VA is founded by David Weintritt MD, a board certified breast surgeon. The National Breast Center provides a comprehensive program for early detection, diagnosis, and treatment of breast cancer, as well as services for those at high risk for breast cancer. The Breast Center combines advanced technology and over...

Thursday 28th September 2017

NightBalance

NightBalance, founded in 2009 and based in The Hague, the Netherlands, developed and markets the Sleep Position Trainer, a proprietary, highly advanced and easy to use device to prevent positional obstructive sleep apnea. CE-marked since 2012, the SPT is currently sold in 11 European countries. NightBalance’s wealth of clinical data supports the efficacy ...

Wednesday 27th September 2017

Engage Therapeutics, Inc.

Engage Therapeutics is a biopharmaceutical company bringing innovative medicines to market. The Company’s lead investigational drug is Staccato® alprazolam, a small, easy-to-use hand-held drug-device combination product that leverages an FDA-approved delivery system with FDA-approved alprazolam for the cessation of active and acute epileptic seizures. Sta...

Tuesday 26th September 2017

Pear Therapeutics

Pear Therapeutics is the leader in prescription digital therapeutics. The company’s approach is to integrate clinically-validated software applications with previously approved pharmaceuticals and treatment paradigms to provide better outcomes for patients, smarter engagement and tracking tools for clinicians, and cost-effective solutions for payers. ...

Synergys Biotherapeutics

Synergys is an early stage company developing multifunctional anti-vascularization antibody drugs targeting VEGF-alternative pathways. The Company’s most advanced product candidate, Anti-EGFR‐TAP (SYN001) was derived from its platform technology termed A‐TAP (Antibody-Targeted Anti-Vascularization Payload). SYN001 is currently in preclinical ...


More From BioPortfolio on "Concurrent Chemoradiation With Cisplatin Every 3 Week in Advanced Cervical Cancer"

Quick Search
Advertisement
 

Corporate Database Quicklinks